Puma Biotechnology (PBYI) Change in Inventory (2017 - 2026)

Puma Biotechnology (PBYI) has 10 years of Change in Inventory data on file, last reported at $3.2 million in Q1 2026.

• Quarterly Change in Inventory rose 11670.37% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$58000.0 (down 103.51% YoY) and the FY2025 annual result came in at -$3.2 million, down 295.19% from the prior year.
• Change in Inventory rose to $3.2 million in Q1 2026, from -$4.0 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $6.1 million in Q4 2024 to a low of -$6.4 million in Q3 2024.
• A 5-year average of $93176.5 and a median of $20000.0 in 2024 frame the typical range for Change in Inventory.
• Annual changes were most pronounced in 2022 — Change in Inventory sank 854.64% — and 2026, when it jumped 11670.37%.
• Tracing PBYI's Change in Inventory over 5 years: stood at -$926000.0 in 2022, then jumped by 251.3% to $1.4 million in 2023, then jumped by 331.91% to $6.1 million in 2024, then plunged by 165.46% to -$4.0 million in 2025, then soared by 180.23% to $3.2 million in 2026.
• The last three Change in Inventory figures came in at $3.2 million (Q1 2026), -$4.0 million (Q4 2025), and $885000.0 (Q3 2025), per Business Quant data.